Cargando…

An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study

Objective To independently evaluate the performance of the QRISK score for predicting 10 year risk of cardiovascular disease in an independent UK cohort of patients from general practice and compare the performance with Framingham equations. Design Prospective open cohort study. Setting 274 practice...

Descripción completa

Detalles Bibliográficos
Autores principales:	Collins, Gary S, Altman, Douglas G
Formato:	Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group Ltd. 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714681/ https://www.ncbi.nlm.nih.gov/pubmed/19584409 http://dx.doi.org/10.1136/bmj.b2584

Ejemplares similares

An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study
por: Collins, Gary S, et al.
Publicado: (2010)

Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2
por: Collins, Gary S, et al.
Publicado: (2012)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
por: Parsons, Ruth E, et al.
Publicado: (2023)

Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores
por: Collins, Gary S, et al.
Publicado: (2011)

Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
por: Hippisley-Cox, Julia, et al.
Publicado: (2017)

Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
por: Zhu, Lisa, et al.
Publicado: (2022)

Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study
por: Livingstone, Shona, et al.
Publicado: (2021)

Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database
por: Hippisley-Cox, Julia, et al.
Publicado: (2010)

QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease
por: Carrillo-Palau, Marta, et al.
Publicado: (2021)

Cardiovascular risk quantification using QRISK-3 score in people with intellectual disability
por: Ho, Jamie Sin Ying, et al.
Publicado: (2021)

Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE—Southall And Brent REvisited)
por: Tillin, Therese, et al.
Publicado: (2013)

QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus
por: Edwards, Nicola, et al.
Publicado: (2018)

Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study
por: Livingstone, Shona J., et al.
Publicado: (2022)

Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus
por: Mu, Xiaodie, et al.
Publicado: (2022)

Sample size considerations for the external validation of a multivariable prognostic model: a resampling study
por: Collins, Gary S., et al.
Publicado: (2015)

Prediction of Cardiovascular Risk Using Framingham, ASSIGN and QRISK2: How Well Do They Predict Individual Rather than Population Risk?
por: van Staa, Tjeerd-Pieter, et al.
Publicado: (2014)

External validation of multivariable prediction models: a systematic review of methodological conduct and reporting
por: Collins, Gary S, et al.
Publicado: (2014)

Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus
por: Vázquez-Del Mercado, Mónica, et al.
Publicado: (2018)

The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
por: Erbasan, V., et al.
Publicado: (2023)

External validation of the QLifetime cardiovascular risk prediction tool: population cohort study
por: Livingstone, Shona, et al.
Publicado: (2023)

Quantitative examination of video-recorded NHS Health Checks: comparison of the use of QRISK2 versus JBS3 cardiovascular risk calculators
por: Gidlow, Christopher J, et al.
Publicado: (2020)

Generalizability of Cardiovascular Disease Clinical Prediction Models: 158 Independent External Validations of 104 Unique Models
por: Gulati, Gaurav, et al.
Publicado: (2022)

External validation of a Cox prognostic model: principles and methods
por: Royston, Patrick, et al.
Publicado: (2013)

Predictors for independent external validation of cardiovascular risk clinical prediction rules: Cox proportional hazards regression analyses
por: Ban, Jong-Wook, et al.
Publicado: (2018)

Identifying patients with undetected colorectal cancer: an independent validation of QCancer (Colorectal)
por: Collins, G S, et al.
Publicado: (2012)

External validation of inpatient neonatal mortality prediction models in high-mortality settings
por: Tuti, Timothy, et al.
Publicado: (2022)

QRISK3® stratification during the Coronavirus pandemic and the evolution of a health promotion opportunity in NHS hospital employees
por: Giri, Prosenjit, et al.
Publicado: (2022)

Predictive role of novel echocardiographic parameter aortic velocity propagation, QRISK3 and Framingham risk score for presence and severity of CAD in Asian patients
por: Vyas, Pooja, et al.
Publicado: (2022)

External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges
por: Riley, Richard D, et al.
Publicado: (2016)

Assessment of Cardiovascular Disease Risk in Adults With Severe Mental Illness Admitted to Acute Psychiatric Unit Using QRISK-3 Assessment Tool: A Quality Improvement Project
por: Elbadrmany, Ibrahim, et al.
Publicado: (2023)

External validation of the PEGeD diagnostic algorithm for suspected pulmonary embolism in an independent cohort
por: Robert-Ebadi, Helia, et al.
Publicado: (2022)

Ten-Year Cardiovascular Risk as Predicted by the QRISK®3 Calculator in Diabetic Patients Attending a Tertiary Care Teaching Hospital in Central India and Its Application to Stratify Statin Over-Users and Under-Users
por: Chandrawanshi, Varnan, et al.
Publicado: (2023)

Validation of the prognostic gene portfolio, ClinicoMolecular Triad Classification, using an independent prospective breast cancer cohort and external patient populations
por: Wang, Dong-Yu, et al.
Publicado: (2014)

Prognostic Prediction Model for Glioblastoma: A Metabolic Gene Signature and Independent External Validation
por: Lei, Chuxiang, et al.
Publicado: (2021)

External validation and clinical utility of prognostic prediction models for gestational diabetes mellitus: A prospective cohort study
por: Meertens, Linda J. E., et al.
Publicado: (2020)

Prognostic Prediction Model for Glioblastoma: A Ferroptosis-Related Gene Prediction Model and Independent External Validation
por: Chen, Wenlin, et al.
Publicado: (2023)

Independent External Validation and Comparison of Death and Kidney Replacement Therapy Prediction Models in Advanced CKD
por: Thanabalasingam, Susan J., et al.
Publicado: (2022)

Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study
por: Clift, Ash Kieran, et al.
Publicado: (2023)

Independent External Validation of FRAX and Garvan Fracture Risk Calculators: A Sub‐Study of the FRISBEE Cohort
por: Baleanu, Felicia, et al.
Publicado: (2021)

External Validations of Cardiovascular Clinical Prediction Models: A Large-Scale Review of the Literature
por: Wessler, Benjamin S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_viqfgld3ujtv03upurjl76knuf